VIVO Projected Dividend Yield
Meridian Bioscience Inc. ( NASDAQ : VIVO )Meridian Bioscience is a life science company with principal businesses in the development, manufacture, sale and distribution of diagnostic testing systems and kits and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, Polymerase Chain Reaction (PCR) master mixes and bioresearch reagents. Co.'s reportable segments are: Diagnostics, which includes diagnostic tests and transport media; and Life Science, which develops, manufactures, sells and distributes bulk antigens, antibodies, immunoassay blocking reagents, PCR master mixes, isothermal reagents, enzymes, nucleotides and bioresearch reagents. 32 YEAR PERFORMANCE RESULTS |
VIVO Dividend History Detail VIVO Dividend News VIVO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2019 |
Jan 24, 2019 |
Feb 01, 2019 |
Feb 04, 2019 |
Feb 14, 2019 |
0.1250 |
2019 Total: |
0.1250 |